GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 513986.38 Face Value (Rs.) : 10 House : Glaxosmithkline - MNC
BSECurrent Price (Rs.) 3034.05Change (Rs.)150.85 (+5.23 %)
PREV CLOSE (Rs.) 2883.20
OPEN PRICE (Rs.) 2854.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 99093
TODAY'S LOW / HIGH (Rs.)2854.85 3051.00
52 WK LOW / HIGH (Rs.)2088 3051
NSECurrent Price (Rs.) 3032.40Change (Rs.)155 (+5.39 %)
PREV CLOSE( Rs. ) 2877.40
OPEN PRICE (Rs.) 2877.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3032.40 (718)
VOLUME 1374693
TODAY'S LOW / HIGH(Rs.) 2851.00 3054.90
52 WK LOW / HIGH (Rs.)2088.1 3054.9

Cash Flow

Select year
(Rs.in Million)
Particulars
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Profit Before Tax
1385.39
1255.19
959.80
841.49
2475.65
Adjustment
-65.25
-68.41
-45.13
-40.00
-1636.48
Changes In working Capital
-98.17
184.83
61.02
-45.75
119.87
Cash Flow after changes in Working Capital
1221.97
1371.61
975.69
755.75
959.04
Cash Flow from Operating Activities
903.30
1289.90
582.02
484.23
810.75
Cash Flow from Investing Activities
396.98
-45.80
8.71
807.85
-405.51
Cash Flow from Financing Activities
-737.08
-769.42
-561.50
-1543.32
-524.24
Net Cash Inflow / Outflow
563.20
474.68
29.23
-251.25
-119.00
Opening Cash & Cash Equivalents
538.85
64.17
34.94
286.19
405.19
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balalces frgn subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
1102.05
538.85
64.17
34.94
286.19